Your account is not claimed yet. You can sign up with ORCID to claim your account.

Lucas Miyake Okumura (Lucas M Okumura)

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2015-2021
Publications (10 Years): 4

Top Topics

Smoking Cessation

Chemotherapy Induced

Health Insurance

Electronic Health Record

Top Venues

JCO global oncology

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

British journal of clinical pharmacology

Pharmacy practice

This page only lists publications with an associated author ORCID identifier.

Publications

Carlos Gil Ferreira, Marcia Datz Abadi, Paula de Mendonça Batista, Fernando Brandão Serra, Rodrigo Buzzatti Peixoto, Lucas Miyake Okumura, Erica Regina Cerqueira
Demographic and Clinical Outcomes of Brazilian Patients With Stage III or IV Non-Small-Cell Lung Cancer: Real-World Evidence Study on the Basis of Deterministic Linkage Approach. JCO global oncology 7 (2021)
Lucas Miyake Okumura, Fernanda D'Athayde Rodrigues, Maria Angelica Pires Ferreira, Leila Beltrami Moreira
Aprepitant in pediatric patients using moderate and highly emetogenic protocols: a systematic review and meta-analyses of randomized controlled trials. British journal of clinical pharmacology 83 (5) (2017)
Lucas Miyake Okumura, Izelandia Veroneze, Celia I Burgardt, Marta F Fragoso
Effects of a computerized provider order entry and a clinical decision support system to improve cefazolin use in surgical prophylaxis: a cost saving analysis. Pharmacy practice 14 (3) (2016)
Lucas Miyake Okumura
Beyond current aprepitant evidence: room for improvement on dose selection and chemotherapy-induced nausea and vomiting risk factors. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 24 (3) (2015)